GPNMB and amyotrophic lateral sclerosis: In a cellular amyotrophic lateral sclerosis model, it has been shown that GPNMB exerts neuroprotective effects by binding to Na/K-ATPase, an ion pump and receptor that modulates neuroinflammation (Ono et al., 2016).